Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Jun 18, 2024
Episode
223
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently approved bispecific T-cell engager, tarlatamab, for small cell lung cancer.
Guest
Anne-Marie Dingemans
MD, PhD
Pulmonologist in the Department of Pulmonary Diseases and Professor of Thoracic Oncology
Erasmus Medical Center
Ryan Gentzler
MD
Associate Professor and Director of the Thoracic Oncology Clinical Research Program
University of Virginia
